Samiclyn is fully licensed by the National Drug Authority (NDA) of Uganda and complies with local and international standards, including Good Distribution Practices (GDP) and Good Manufacturing Practices (GMP) as outlined by the World Health Organization (WHO). We partner with manufacturers holding:
WHO Good Manufacturing Practices (WHO-GMP)
ISO 9001:2015 (Quality Management Systems)
U.S. Food and Drug Administration (FDA) approvals
European Medicines Agency (EMA) standards
2025: Incorporated in Kampala, Uganda, and launched operations with initial product portfolio.
2025: Established partnerships with WHO-GMP certified manufacturers and secured NDA licensing.
2025: Initiated community outreach programs, including CME sessions and health awareness campaigns.